Corcept Therapeutics Incorporated (0I3Q)
Market Closed
17 Jul, 15:30
$
89. 76
-1.94
-2.1156%
$
5.86B Market Cap
- P/E Ratio
- Div Yield
398 Volume
- Eps
$ 91.7
Previous Close Want to track 0I3Q and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Corcept Therapeutics Incorporated (0I3Q) Statistics
Valuation metrics
Market Cap 5.86B
Enterprise value 9.62B
Trailing P/E (ttm) 201.16
Forward P/E -
PEG ratio -3.12
Price/Sales (ttm) 12.63
Price/Book (mrq) 14.82
Enterprise Value/Revenue 12.51
Enterprise Value/EBITDA 679.46
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 708
Average volume (90 days) 721
Price summary
52-Week low 28.67
52-Week high 96.64
Beta -
50-Day moving average 83.53
200-Day moving average 52.87
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.06%
Operating margin -0.01%
Operational effectiveness
Return on assets 0.06%
Return on equity 0.08%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 7.36
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.46
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.24
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 2.86%
Book value per share (mrq) 6.11
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
